UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.275-285

2017

Volltextzugriff (PDF)

A biochemical definition of cure after brachytherapy for prostate cancer

Radiotherapy and oncology, 2020-08, Vol.149, p.64-69

2020

Volltextzugriff (PDF)

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.286-295

2017

Volltextzugriff (PDF)

Multi-Frequency 3D Shear Wave Absolute Vibro-Elastography (S-WAVE) System for the Prostate

IEEE transactions on medical imaging, 2023-11, Vol.PP (11), p.1-1

2023

Volltextzugriff (PDF)

Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer

Cancer, 2013-04, Vol.119 (8), p.1537-1546

2013

Volltextzugriff (PDF)

In Reply to Hamstra et al

International journal of radiation oncology, biology, physics, 2017-06, Vol.98 (2), p.482-482

Morris, W. James, MD, FRCPC

2017

Volltextzugriff (PDF)

Predictive Factors for Acute and Late Urinary Toxicity After Permanent Prostate Brachytherapy: Long-Term Outcome in 712 Consecutive Patients

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (4), p.1023-1032

2009

Volltextzugriff (PDF)

Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival

International journal of radiation oncology, biology, physics, 2014, Vol.88 (1), p.87-93

2014

Volltextzugriff (PDF)

Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A Single-Institution Matched-Pair Analysis

International journal of radiation oncology, biology, physics, 2010-01, Vol.76 (1), p.43-49

2010

Volltextzugriff (PDF)

Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (3), p.570-578

2014

Volltextzugriff (PDF)

Treatment options for localized prostate cancer

Canadian family physician, 2013-12, Vol.59 (12), p.1269-1274

2013

Volltextzugriff (PDF)

Registration of trans-perineal template mapping biopsy cores to volumetric ultrasound

International journal for computer assisted radiology and surgery, 2022-05, Vol.17 (5), p.929-936

2022

Volltextzugriff (PDF)

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6132-6138

2005

Volltextzugriff (PDF)

ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2017-07, Vol.98 (3), p.581-589

2017

Volltextzugriff (PDF)

Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Abbreviated Systemic Therapy and Consolidation Radiotherapy: Involved-Field Versus Involved-Node Radiotherapy

Cancer, 2012-09, Vol.118 (17), p.4156-4165

2012

Volltextzugriff (PDF)

Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours

Brachytherapy, 2020-09, Vol.19 (5), p.589-598

2020

Volltextzugriff (PDF)

Incidence of Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (4), p.934-941

2014

Volltextzugriff (PDF)

An Updated Analysis of the Survival Endpoints of ASCENDE-RT

International journal of radiation oncology, biology, physics, 2023-04, Vol.115 (5), p.1061-1070

2023

Volltextzugriff (PDF)

Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients

International journal of radiation oncology, biology, physics, 2015-03, Vol.91 (4), p.745-751

2015

Volltextzugriff (PDF)

Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial

Brachytherapy, 2018-11, Vol.17 (6), p.837-844

2018

Volltextzugriff (PDF)

Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia

Canadian Urological Association journal, 2015-11, Vol.9 (11-12), p.409-413

2015

Volltextzugriff (PDF)

DNA Ploidy Measured on Archived Pretreatment Biopsy Material May Correlate With Prostate-Specific Antigen Recurrence After Prostate Brachytherapy

International journal of radiation oncology, biology, physics, 2013-08, Vol.86 (5), p.829-834

2013

Volltextzugriff (PDF)

In Regard to Ciezki et al

International journal of radiation oncology, biology, physics, 2017-09, Vol.99 (1), p.240-242

2017

Volltextzugriff (PDF)

Low soil phosphorus availability triggers maize growth stage specific rhizosphere processes leading to mineralization of organic P

Plant and soil, 2021-02, Vol.459 (1-2), p.423-440

2021

Volltextzugriff (PDF)

Biochemical Control With Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90

International journal of radiation oncology, biology, physics, 2012-05, Vol.83 (1), p.22-27

2012

Volltextzugriff (PDF)

1 – 25 von 2.227

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.893)
Mit Volltextzugriff
(1.783)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.058)
EZB Electronic Journals Library
(918)
Ingenta
(830)
Ovid Journals
(746)
Publisher
(581)
Access via ScienceDirect (Elsevier)
(402)
IngentaConnect Journals
(308)
Wiley Journals
(280)
JSTOR All Journals
(271)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(244)
Wiley Online Library
(191)
Access via Oxford University Press
(122)
Nature Journals
(122)
SpringerLink
(120)
Taylor & Francis
(94)
Nexis Uni
(86)
Access via Taylor & Francis
(84)
Oxford Journals 2020 Medicine
(84)
Access via Taylor & Francis
(74)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(67)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A biochemical definition of cure after brachytherapy for prostate cancer

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

Multi-Frequency 3D Shear Wave Absolute Vibro-Elastography (S-WAVE) System for the Prostate

Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer

In Reply to Hamstra et al

Predictive Factors for Acute and Late Urinary Toxicity After Permanent Prostate Brachytherapy: Long-Term Outcome in 712 Consecutive Patients

Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival

Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A Single-Institution Matched-Pair Analysis

Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals

Treatment options for localized prostate cancer

Registration of trans-perineal template mapping biopsy cores to volumetric ultrasound

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Abbreviated Systemic Therapy and Consolidation Radiotherapy: Involved-Field Versus Involved-Node Radiotherapy

Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours

Incidence of Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy

An Updated Analysis of the Survival Endpoints of ASCENDE-RT

Patterns of Recurrence After Low-Dose-Rate Prostate Brachytherapy: A Population-Based Study of 2223 Consecutive Low- and Intermediate-Risk Patients

Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial

Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia

DNA Ploidy Measured on Archived Pretreatment Biopsy Material May Correlate With Prostate-Specific Antigen Recurrence After Prostate Brachytherapy

In Regard to Ciezki et al

Low soil phosphorus availability triggers maize growth stage specific rhizosphere processes leading to mineralization of organic P

Biochemical Control With Radiotherapy Improves Overall Survival in Intermediate and High-Risk Prostate Cancer Patients Who Have an Estimated 10-Year Overall Survival of >90

Suchergebnisse filtern